Venture capital deal volume in the healthcare industry continued its downward trend in the third quarter, according to the latest report from a venture research firm.
The number of third-quarter healthcare venture deals stood at 143, the lowest in at least five quarters, according to New York-based CB Insights. The number represented a decline of 22 percent from the year-ago quarter, but a drop of just 3 percent from the second quarter.
“With chatter about an unfriendly regulatory landscape getting louder and a generally uncertain exit environment, healthcare venture capital continued its consistent trend downwards,” the report said.
Indeed, industry complaints about regulators — never the most popular people with the business community in the first place — have only seemed to grow louder this year.
To read the full, original article click on this link: Healthcare venture capital deal volume continues to slide
Author:Brandon Glenn
